EU To Post Comments On Drug Sector Antitrust Probe

Law360, New York (February 3, 2009, 12:00 AM EST) -- The European Commission reportedly plans to disclose public comments it has received following its inquiry into whether major pharmaceutical companies have been involved in a scheme to delay or block the sale of generic versions of their drugs.

EU spokesman Jonathan Todd said Monday that the commission received more than 40 submissions during a consultation period that ended late last month and that they will be posted on the regulator’s Web site within the next few weeks, according to European news publication EurActiv.

The commission published...
To view the full article, register now.